{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:47:11Z","timestamp":1782560831052,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bonr.2026.101918","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:25:10Z","timestamp":1776180310000},"page":"101918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bone turnover in postmenopausal women during denosumab treatment: Biomarker analysis in naive and discontinuing patients"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9094-6021","authenticated-orcid":false,"given":"Mikolaj","family":"Bartosik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2653-7834","authenticated-orcid":false,"given":"Esther","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-8983","authenticated-orcid":false,"given":"Alexander","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-6794","authenticated-orcid":false,"given":"Felix N.","family":"von Brackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7522-4887","authenticated-orcid":false,"given":"Oskar","family":"Windels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5926-2843","authenticated-orcid":false,"given":"Ulrich C.","family":"Klostermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0200-8431","authenticated-orcid":false,"given":"Florian","family":"Barvencik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-8348","authenticated-orcid":false,"given":"Michael","family":"Amling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-5013","authenticated-orcid":false,"given":"Ralf","family":"Oheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2026.101918_bb0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF01321832","article-title":"Impairment of bone turnover in elderly women with hip fracture","volume":"53","author":"Akesson","year":"1993","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2026.101918_bb0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101918_bb0015","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101918_bb0020","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/jbmr.4335","article-title":"Fractures after denosumab discontinuation: a retrospective study of 797 cases","volume":"36","author":"Burckhardt","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101918_bb0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000013602","article-title":"Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure","volume":"20","author":"Coen","year":"2000","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.bonr.2026.101918_bb0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2026.101918_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2025.105954","article-title":"Strategies for denosumab discontinuation in postmenopausal osteoporosis","volume":"93","author":"Degbo\u00e9","year":"2026","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bonr.2026.101918_bb0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jbmr.5650060615","article-title":"Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis","volume":"6","author":"Delmas","year":"1991","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 6","key":"10.1016\/j.bonr.2026.101918_bb0045","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101918_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1359\/jbmr.1997.12.1.59","article-title":"Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis","volume":"12","author":"Eastell","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101918_bb0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101918_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115830","article-title":"Risk factors for vertebral fractures and bone loss after denosumab discontinuation: a real-world observational study","volume":"144","author":"Everts-Graber","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101918_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/v10039-009-0003-x","article-title":"Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes","volume":"54","author":"Fassbender","year":"2009","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.bonr.2026.101918_bb0070","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1359\/jbmr.2003.18.5.859","article-title":"The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation","volume":"18","author":"Garnero","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101918_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/clinchem\/41.4.571","article-title":"Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability","volume":"41","author":"Gerrits","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bonr.2026.101918_bb0080","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bonr.2026.101918_bb0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0004563213515190","article-title":"Biochemical markers of bone turnover \u2013 uses and limitations","volume":"51","author":"Hlaing","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bonr.2026.101918_bb0090","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jocd.2019.09.001","article-title":"Cross-calibration, least significant change and quality assurance in multiple dual-energy x-ray absorptiometry scanner environments: 2019 ISCD official position","volume":"22","author":"Jankowski","year":"2019","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bonr.2026.101918_bb0095","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/clinchem\/43.9.1570","article-title":"Comparison of analytical performance and biological variability of three bone resorption assays","volume":"43","author":"Ju","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bonr.2026.101918_bb0100","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00198-009-1108-6","article-title":"Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid","volume":"21","author":"Kaji","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101918_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116764","article-title":"Maintenance of bone resorption markers in the low premenopausal range during the year following denosumab discontinuation is associated to bone density preservation. The ReoLaus study","volume":"172","author":"Liebich","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101918_bb0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2026.101918_bb0115","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1359\/jbmr.1997.12.7.1083","article-title":"Relationship of bone turnover to bone density and fractures","volume":"12","author":"Melton","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101918_bb0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101918_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00774-003-0460-4","article-title":"Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline","volume":"22","author":"Okabe","year":"2004","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bonr.2026.101918_bb0130","first-page":"97","article-title":"Biochemical markers of bone turnover: part I: biochemistry and variability","volume":"26","author":"Seibel","year":"2005","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.bonr.2026.101918_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00223-001-1059-1","article-title":"Biochemical markers of bone turnover in men","volume":"69","author":"Szulc","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2026.101918_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101918_bb0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/clinem\/dgaa756","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","volume":"106","author":"Tsourdi","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101918_bb0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101918_bb0155","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1302\/0301-620X.88B7.16564","article-title":"Urinary excretion of deoxypyridinoline in Perthes\u2019 disease: a prospective, controlled comparative study in 83 children","volume":"88","author":"Westhoff","year":"2006","journal-title":"J. Bone Joint Surg. (Br.)"},{"key":"10.1016\/j.bonr.2026.101918_bb0160","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/clinchem\/45.10.1858","article-title":"Diurnal rhythm of CrossLaps in human serum","volume":"45","author":"Wichers","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bonr.2026.101918_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00198-017-4242-6","article-title":"Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study","volume":"29","author":"Zanchetta","year":"2018","journal-title":"Osteoporos. Int."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:29:47Z","timestamp":1782559787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187226000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S2352187226000227"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101918","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone turnover in postmenopausal women during denosumab treatment: Biomarker analysis in naive and discontinuing patients","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101918"}}